Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDS-943 in Osteoarthritis of the Knee
NCT00546832Phase 3Completed
- Sponsor
- Mika Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of TDS-943 in osteoarthritis (OA) (3 arms), sponsored by Mika Pharmaceuticals. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Pain at 30 days. Started Oct 2007; status: completed.
02
Drugs
TDS-943
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00546832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546832.